An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons

Jesús Saavedra-Lozano, Cynthia McCoig, Jinbo Xu, Yanying Cao, Philip Keiser, Victor Ghetie, Robert F. Siliciano, Janet D. Siliciano, Louis J. Picker, Octavio Ramilo, Ellen S. Vitetta

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Highly active antiretroviral therapy has decreased the morbidity and mortality of human immunodeficiency virus (HIV) infection, but latently infected cells remain for prolonged periods. CD4+ CD45RO+ T cells are a major latent virus reservoir in HIV-infected persons. Replication-competent, latently HIV-infected T cells can be generated in vitro by infecting peripheral blood mononuclear cells with HIV and then eliminating the HIV-producing cells with an anti-CD25 immunotoxin (IT). The CD25- latently infected cells then can be eliminated with an anti-CD45RO IT. This study determined whether this IT also could kill latently infected CD4 T cells from HIV-infected persons with or without detectable plasma viremia. The results show that ex vivo treatment of cells from HIV-positive persons by anti-CD45RO IT reduces the frequency of both productively and latently infected cells. In contrast, CD4+ CD45A+ naive T cells and a proportion of CD4+ CD45ROlo memory T cells are spared.

Original languageEnglish (US)
Pages (from-to)306-314
Number of pages9
JournalJournal of Infectious Diseases
Volume185
Issue number3
DOIs
StatePublished - Feb 1 2002
Externally publishedYes

Fingerprint

Immunotoxins
HIV
T-Lymphocytes
Viremia
Highly Active Antiretroviral Therapy
Virus Diseases
Blood Cells
Viruses
Morbidity
Mortality

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons. / Saavedra-Lozano, Jesús; McCoig, Cynthia; Xu, Jinbo; Cao, Yanying; Keiser, Philip; Ghetie, Victor; Siliciano, Robert F.; Siliciano, Janet D.; Picker, Louis J.; Ramilo, Octavio; Vitetta, Ellen S.

In: Journal of Infectious Diseases, Vol. 185, No. 3, 01.02.2002, p. 306-314.

Research output: Contribution to journalArticle

Saavedra-Lozano, J, McCoig, C, Xu, J, Cao, Y, Keiser, P, Ghetie, V, Siliciano, RF, Siliciano, JD, Picker, LJ, Ramilo, O & Vitetta, ES 2002, 'An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons', Journal of Infectious Diseases, vol. 185, no. 3, pp. 306-314. https://doi.org/10.1086/338565
Saavedra-Lozano, Jesús ; McCoig, Cynthia ; Xu, Jinbo ; Cao, Yanying ; Keiser, Philip ; Ghetie, Victor ; Siliciano, Robert F. ; Siliciano, Janet D. ; Picker, Louis J. ; Ramilo, Octavio ; Vitetta, Ellen S. / An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons. In: Journal of Infectious Diseases. 2002 ; Vol. 185, No. 3. pp. 306-314.
@article{8de0dcf637784ba2aea0bbb384c04c46,
title = "An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons",
abstract = "Highly active antiretroviral therapy has decreased the morbidity and mortality of human immunodeficiency virus (HIV) infection, but latently infected cells remain for prolonged periods. CD4+ CD45RO+ T cells are a major latent virus reservoir in HIV-infected persons. Replication-competent, latently HIV-infected T cells can be generated in vitro by infecting peripheral blood mononuclear cells with HIV and then eliminating the HIV-producing cells with an anti-CD25 immunotoxin (IT). The CD25- latently infected cells then can be eliminated with an anti-CD45RO IT. This study determined whether this IT also could kill latently infected CD4 T cells from HIV-infected persons with or without detectable plasma viremia. The results show that ex vivo treatment of cells from HIV-positive persons by anti-CD45RO IT reduces the frequency of both productively and latently infected cells. In contrast, CD4+ CD45A+ naive T cells and a proportion of CD4+ CD45ROlo memory T cells are spared.",
author = "Jes{\'u}s Saavedra-Lozano and Cynthia McCoig and Jinbo Xu and Yanying Cao and Philip Keiser and Victor Ghetie and Siliciano, {Robert F.} and Siliciano, {Janet D.} and Picker, {Louis J.} and Octavio Ramilo and Vitetta, {Ellen S.}",
year = "2002",
month = "2",
day = "1",
doi = "10.1086/338565",
language = "English (US)",
volume = "185",
pages = "306--314",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons

AU - Saavedra-Lozano, Jesús

AU - McCoig, Cynthia

AU - Xu, Jinbo

AU - Cao, Yanying

AU - Keiser, Philip

AU - Ghetie, Victor

AU - Siliciano, Robert F.

AU - Siliciano, Janet D.

AU - Picker, Louis J.

AU - Ramilo, Octavio

AU - Vitetta, Ellen S.

PY - 2002/2/1

Y1 - 2002/2/1

N2 - Highly active antiretroviral therapy has decreased the morbidity and mortality of human immunodeficiency virus (HIV) infection, but latently infected cells remain for prolonged periods. CD4+ CD45RO+ T cells are a major latent virus reservoir in HIV-infected persons. Replication-competent, latently HIV-infected T cells can be generated in vitro by infecting peripheral blood mononuclear cells with HIV and then eliminating the HIV-producing cells with an anti-CD25 immunotoxin (IT). The CD25- latently infected cells then can be eliminated with an anti-CD45RO IT. This study determined whether this IT also could kill latently infected CD4 T cells from HIV-infected persons with or without detectable plasma viremia. The results show that ex vivo treatment of cells from HIV-positive persons by anti-CD45RO IT reduces the frequency of both productively and latently infected cells. In contrast, CD4+ CD45A+ naive T cells and a proportion of CD4+ CD45ROlo memory T cells are spared.

AB - Highly active antiretroviral therapy has decreased the morbidity and mortality of human immunodeficiency virus (HIV) infection, but latently infected cells remain for prolonged periods. CD4+ CD45RO+ T cells are a major latent virus reservoir in HIV-infected persons. Replication-competent, latently HIV-infected T cells can be generated in vitro by infecting peripheral blood mononuclear cells with HIV and then eliminating the HIV-producing cells with an anti-CD25 immunotoxin (IT). The CD25- latently infected cells then can be eliminated with an anti-CD45RO IT. This study determined whether this IT also could kill latently infected CD4 T cells from HIV-infected persons with or without detectable plasma viremia. The results show that ex vivo treatment of cells from HIV-positive persons by anti-CD45RO IT reduces the frequency of both productively and latently infected cells. In contrast, CD4+ CD45A+ naive T cells and a proportion of CD4+ CD45ROlo memory T cells are spared.

UR - http://www.scopus.com/inward/record.url?scp=0036467792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036467792&partnerID=8YFLogxK

U2 - 10.1086/338565

DO - 10.1086/338565

M3 - Article

VL - 185

SP - 306

EP - 314

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 3

ER -